In line with these observations, 89Zi uptake in the tumor was higher in patients with mismatch repair deficiency (dMMR) than in MMR-proficient (pMMR) patients, which is consistent with reports of enhanced CD8+ T cell infiltration in dMMR tumors. Here, CD8A is linked to neoplasm.